Source: Virtual Congress 2021 – COVID - 19 biomarkers



Rating:

Share or cite this content

Citations should be made in the following way:
R. Abdullaev (Moscow, Russian Federation), O. Komissarova (Moscow, Russian Federation), Y. Berezovskiy (Moscow, Russian Federation), E. Gretsov (Moscow, Russian Federation). Indicators of systemic inflammation in critically ill patients with COVID-19.. 644

Member's Comments

No comment yet.

Related content which might interest you: Impact of pulmonary rehabilitation on sequelae produced in critically ill patients by COVID-19. Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021 Indicators of hemostasis and fibrinolysis systems in critically ill patients with COVID-19. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 How can I prevent infectious complications in critically ill patients? Source: Annual Congress 2008 - PG13 - Respiratory failure: skills needed to treat an episode of acute respiratory failure Year: 2008 Resistin may predict severity and mortality in critically ill septic patients Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 Nutritional status and its impact on the outcome in critically ill COPD patients Source: Annual Congress 2009 - Intensive care unit management and outcome Year: 2009 Antibiotics in the critically ill and septic patient Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections Year: 2013 Body mass index and pulmonary complications in critically ill black patients Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 LATE-BREAKING ABSTRACT: The evolution of procalcitonin as a prognostic factor in critically ill patients with sepsis Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015 Clinically important drug interactions with anti-infective agents in critically ill patients with respiratory disorders Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016 Steroid use in elderly critically ill COVID-19 patients Source: Eur Respir J, 58 (4) 2100979; 10.1183/13993003.00979-2021 Year: 2021 The relationship between delayed anti-TB treatment and hospital mortality in critically ill patients Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a perspective study Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Low serum selenium levels in critically ill patients with respiratory diseases are associated with poor prognostic and nutritional factors: A prospective observational study Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Why tracheostomy in critically ill patients? Source: Annual Congress 2008 - Tracheostomy in critically ill patients Year: 2008 Which tracheostomy in critically ill patients? Source: Annual Congress 2008 - Tracheostomy in critically ill patients Year: 2008 Predicting survival in hospitalized pulmonary hypertension patients Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Breath markers in critically ill patients Source: Annual Congress 2004 - New tools and new concepts in respiratory monitoring Year: 2004 Alterations in serum lipid profile in critically ill septic patients: a prospective study Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020